Dr. Delafontaine said he will step down from the Columbia-based medical school March 31 to become executive dean at New Orleans-based Tulane University School of Medicine.
“The school is on an upward trajectory across its three main missions and I shall be cheering you on as you continue to take our school to new heights. The many accomplishments of the school would not have been possible without your dedication and hard work and I am immensely grateful for your efforts and the support you have shown me during my tenure,” he wrote in the letter, obtained by the publication.
Dr. Delafontaine’s four-year tenure as head of the medical school saw its fair share of controversy. He resigned after less than a year at the helm in 2015, but was reinstated as dean in February 2016, according to the report.
University officials appointed Steven Zweig, MD, interim dean. Dr. Zweig joined the medical school’s family and community medicine faculty in 1984.
To access the full report, click here.
More articles on physician integration issues:
Why do clinicians resist interoperability?
Match Day 2019 largest in history — 4 notes
Scholarship named for physician killed in Chicago hospital shooting
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
